Home/Filings/4/0001821825-25-000014
4//SEC Filing

WALSH MATTHEW M 4

Accession 0001821825-25-000014

CIK 0001821825other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:41 PM ET

Size

23.0 KB

Accession

0001821825-25-000014

Insider Transaction Report

Form 4
Period: 2025-03-31
WALSH MATTHEW M
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-31$14.51/sh5,933$86,088129,149 total
  • Award

    Restricted Stock Units

    2025-03-31+64,64064,640 total
    Common Stock (64,640 underlying)
  • Tax Payment

    Common Stock

    2025-03-31$14.51/sh3,819$55,414133,084 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-3115,07030,142 total
    Common Stock (15,070 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-317,7540 total
    Common Stock (7,754 underlying)
  • Tax Payment

    Common Stock

    2025-03-31$14.51/sh7,422$107,693123,036 total
  • Exercise/Conversion

    Common Stock

    2025-03-31+15,070130,458 total
  • Exercise/Conversion

    Common Stock

    2025-03-31+12,046135,082 total
  • Exercise/Conversion

    Common Stock

    2025-03-31+7,754136,903 total
  • Award

    Stock Option (right to buy)

    2025-03-31+317,656317,656 total
    Exercise: $14.89Common Stock (317,656 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-3112,04612,047 total
    Common Stock (12,046 underlying)
Footnotes (7)
  • [F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
  • [F2]The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
  • [F3]Each RSU converts into one share of Organon common stock.
  • [F4]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
  • [F5]On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
  • [F6]On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
  • [F7]On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.

Issuer

Organon & Co.

CIK 0001821825

Entity typeother

Related Parties

1
  • filerCIK 0001269428

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:41 PM ET
Size
23.0 KB